Skip to main content
Erschienen in: BMC Gastroenterology 1/2015

Open Access 01.12.2015 | Research article

Comparison of the usefulness of endoscopic papillary large-balloon dilation with endoscopic sphincterotomy for large and multiple common bile duct stones

verfasst von: Kouhei Tsuchida, Mari Iwasaki, Misako Tsubouchi, Tsunehiro Suzuki, Chieko Tsuchida, Naoto Yoshitake, Takako Sasai, Hideyuki Hiraishi

Erschienen in: BMC Gastroenterology | Ausgabe 1/2015

Abstract

Background

Endoscopic sphincterotomy (EST) is currently recognized as the primary endoscopic treatment for common bile duct stones. However, it is difficult to remove multiple (≥3) or large (≥15 mm) common bile duct stones with EST alone. Recently, EST plus endoscopic papillary large-balloon dilation (EPLBD) was reported to be an effective treatment for such bile duct stones. We compared the results of EST and EST + EPLBD for multiple (≥3) or large (≥15 mm) stones that were difficult to treat using EST alone. We also compared the complication rates between the techniques.

Methods

Seventy patients with large (largest diameter, ≥15 mm) or ≥ 3 common bile duct stones treated in our department between April 2010 and March 2013 underwent EST + EPLBD (n = 34) or EST alone (n = 36). We compared final successful stone removal rates, rates of successful stone removal in the first session, procedure times, status of concurrent mechanical lithotripsy (ML), and complications between the EST + EPLBD and EST groups.

Results

The rates of final successful stone removal were similar between the two groups (EST + EPLBD: 100 % vs. EST: 89 %; p = 0.115). The rate of successful stone removal in the first session was significantly higher in the EST + EPLBD group (EST + EPLBD: 88 % vs. EST: 56 %; p = 0.03). Moreover, the procedure time was significantly shorter (EST + EPLBD: 42 min vs. EST: 67 min; p = 0.011) and the rate of ML use was significantly lower in the EST + EPLBD group (EST + EPLBD: 50 % vs. EST: 94 %; p < 0.001). Complications like pancreatitis and bleeding occurred in three patients in the EST + EPLBD group and in 10 patients in the EST group, but the differences were not statistically significant (EST + EPLBD: 9 % vs. EST: 25 %; p = 0.112).

Conclusions

Our results suggest that EST + EPLBD is an effective therapy for patients with difficult-to-treat multiple or large common bile duct stones, because it requires fewer sessions and shorter operative times than EST alone.
Hinweise

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

KT was involved in the study design and manuscript drafting. KT, MI, MT, and NY performed the endoscopic treatment. KT, MI, MT, TS, and CT performed data collection and statistical analyses. NY, TS, and HH provided advice on the manuscript. NY and HH participated in the study design and helped in manuscript drafting. All authors read and approved the final manuscript.
Abkürzungen
EST
Endoscopic sphincterotomy
EPLBD
Endoscopic papillary large-balloon dilation
EML
Endoscopic mechanical lithotripsy
ML
Mechanical lithotripsy
ERCP
Endoscopic retrograde cholangiopancreatography
APC
Argon plasma coagulation

Background

Endoscopic sphincterotomy (EST) is widely recognized as a standard endoscopic treatment for common bile duct stones. However, stone removal with EST alone is often difficult in patients with large or multiple stones, damaged common bile ducts, or tortuous distal bile ducts [14]. In 1982, endoscopic mechanical lithotripsy (EML) using a mechanical lithotripter was proposed [5] and proved useful as a concomitant treatment in these difficult-to-treat patients. There is, however, concern that recurrence rates of common bile duct stones increase with the use of ML [6, 7]. In 2003, Ersoz et al. [8] reported the use of EST plus endoscopic papillary large-balloon dilation (EPLBD), and the usefulness of this innovation in patients with difficult-to-remove stones has gradually become evident. This combination is a promising new endoscopic technique for the treatment of common bile duct stones, with efficacy similar to that of EST. However, there is no consensus yet on the usefulness of EST + EPLBD compared with that of EST alone or with concurrent EML. Concrete evidence based on accumulated research findings is needed. This study compares the use of EST with EST + EPLBD and evaluates adverse events in patients with large (≥15 mm) or multiple (≥3) common bile duct stones.

Methods

Patients

This study included 70 patients (37 men, 33 women) who had either a single common bile duct stone ≥15 mm or more than three stones. All patients underwent endoscopic treatment between April 2011 and October 2013 at the Department of Gastroenterology, Dokkyo Medical University. We examined the final successful stone removal rate, number of stone removal sessions, successful stone removal rate in the first session, procedure time, status of concomitant ML, and complications.
This study protocol was approved by the ethics committee of Dokkyo Medical University. All patients gave written informed consent before the procedure.

EST and EST + EPLBD

EST + EPLBD was introduced in our hospital in September 2012. Prior to its introduction, EST was the first-line therapy for multiple or large common bile duct stones. Since its introduction, EST + EPLBD has been used as the first-line therapy in patients, except those who are under 60 years of age and those in whom the distal bile duct cannot be sufficiently dilated.

Endoscopic technique

Prior to endoscopic treatment, patients were sedated with pentazocine (15 mg) and buprenorphine hydrochloride (3–6 mg). At the time of endoscopic retrograde cholangiopancreatography (ERCP), a protease inhibitor and an antimicrobial agent were administered to prevent pancreatitis and infection [9, 10].
After confirming that the patients were adequately sedated, ERCP was performed using a side-viewing endoscope (JF-260 V, Olympus Medical Systems, Co. Ltd, Tokyo, Japan). At the time of ERCP, an ERCP catheter (MTW Endoscopy, Goldsbergstraße, Germany) was used for contrast-enhanced catheterization and a jag wire (Boston Scientific Japan, Tokyo, Japan) served as the guide wire. After the common bile duct was selectively imaged, the sizes and number of stones were confirmed and the diameter of the distal bile duct was measured simultaneously (Fig. 1). The diameter of the EPLBD balloon (CRE, Boston Scientific Japan, Tokyo, Japan) was selected to correspond to the diameter of the distal bile duct. In all patients, EST was performed before EPLBD (Fig. 2).
After EPLBD balloon insertion into the papilla, the balloon was gradually pressurized until waist disappearance using a special device, and balloon dilation was maintained for 15 s thereafter (Fig. 3). The balloon was removed, and the stones were then extracted using a retrieval balloon catheter (Extractor™ Pro RX, Boston Scientific Japan, Tokyo, Japan) or a basket catheter (FG-V425PR1, Olympus Medical Systems, Co. Ltd, Tokyo, Japan). In patients with difficult-to-extract stones, the stones were removed after being crushed using ML (BML-V437QR-30, Olympus Medical Systems, Co. Ltd, Tokyo, Japan) (Fig. 4). To confirm the presence of any remaining stones, the patients underwent contrast-enhanced imaging after occlusion with a retrieval balloon catheter. If the stones could not be removed completely in the first session, another session with plastic stent insertion was performed later.

Evaluation of stone removal

Stone removal was considered successful when no remaining radiolucent stones were visible on contrast-enhanced imaging after occlusion with a retrieval balloon.

Procedure time

The operative time was defined as the amount of time required from frontal imaging of Vater’s papilla to the end of the stone removal procedure.

Evaluation of complications

Post-ERCP pancreatitis, bleeding, and perforation were evaluated. Pancreatitis was diagnosed according to Cotton’s criteria for post-ERCP pancreatitis [11]. Bleeding was defined as a hemoglobin level decrease of at least 2 g/dL from baseline within 24 h after the procedure or bleeding significant enough to require hemostasis. The presence or absence of perforation was evaluated using endoscopic images as well as postoperative survey radiography and computed tomography.

Statistical analysis

Each variable was statistically analyzed using the chi-square test, Fisher’s exact test, or Student’s t-test. A value of p < 0.05 was considered statistically significant.

Results

Table 1 shows the characteristics of the 70 patients in the study, all of whom received endoscopic treatment for a single stone ≥15 mm (largest diameter) or for multiple stones (more than three). Age, sex, mean number of stones, mean diameter of stones, mean diameter of the bile duct, presence or absence of periampullary diverticula, and history of previous cholecystectomy were assessed. No statistically significant differences were observed between the two groups for any of these factors. Eighteen patients (52.9 %) in the EST + EPLBD group and 19 patients (52.8 %) in the EST group had more than three stones. The mean number and mean maximum diameter of stones were, respectively, 5.5 ± 2.6 and 16.6 ± 3.4 mm in the EST + EPLBD group and 4.5 ± 1.7 stones and 18.4 ± 5.6 mm in the EST group.
Table 1
Characteristics of patients
 
EST + EPLBD (n = 34)
EST (n = 36)
P value
Gender (M/F)
17/17
20/16
0.821
Age (years, mean ± SD)
78.50 ± 1.85
74.19 ± 1.97
0.117
Size of stone (mm, mean ± SD)
18.29 ± 1.02
18.206 ± 0.75
0.944
No of stones (n, mean ± SD)
3.50 ± 0.49
2.97 ± 0.34
0.376
Diameter of bile duct (mm, mean ± SD)
15.42 ± 0.49
16.59 ± 0.75
0.198
Periampullary diverticulum (%)
70.59
61.11
0.560
Previous cholecystectomy (%)
8.82
25
0.072
Comorbidities
   
Hypertension (n)
26
18
0.040
Heart disease (n)
8
7
0.901
Cranial nerve disease (n)
8
9
0.999
Diabetes mellitus (n)
9
7
0.678
Complete stone removal was achieved in all 34 patients in the EST + EPLBD group (100 % stone removal rate) but in only 32/36 patients in the EST group (88 % stone removal rate). This difference was not statistically significant (p = 0.115). The EST + EPLBD group showed a higher rate of complete stone removal in the first session (EST + EPLBD: 88.2 % vs. EST: 55.6 %; p = 0.003) and a lower mean number of sessions required for complete stone removal (EST + EPLBD: 1.12 sessions vs. EST: 1.47; p = 0.002). In addition, fewer patients underwent concomitant ML in the EST + EPLBD group (EST + EPLBD: 50.0 % vs. EST: 94.4 %; p < 0.001). The mean procedure time was 66.6 min in the EST group and 42.3 min in the EST + EPLBD group, which indicated a significantly shorter procedure time in the latter (p = 0.011). No significant difference was observed in the mean length of hospital stay between the two groups (Table 2). Because the majority of patients underwent treatment for acute suppurative cholangitis and stone removal during a single hospital stay, the length of hospital stay was long. Patients who were admitted at the onset of acute obstructive suppurative cholangitis accounted for 73.5 % of the EST + EPLBD group and 69.4 % of the EST group.
Table 2
Comparison between EST + EPLBD and EST
 
EST + EPLBD (n = 34)
EST (n = 36)
P value
Complete removal of stone (%)
100
88.9
0.115
No of session
1.1
1.5
0.002
Complete stone removal in 1st session (%)
88.2
55.6
0.003
Use of Mechanical lithotripsy (%)
50
94.4
<0.001
Procedure time (min)
42.3
66.6
0.010
Hospitalization (day)
17.7
20.2
0.160
The cause of stone removal failure in all four unsuccessful EST group patients was the presence of large stacked stones, which resulted in insufficient ML dilation making it difficult to crush the stones. A 7-Fr plastic stent was placed in all four patients and biliary drainage was performed. One patient received surgical treatment. The other three were considered poor candidates for general anesthesia because of advanced age or underlying diseases. These three patients continue to be monitored with regular replacement of their plastic stents.
Table 3 shows complications in all patients. No significant differences were observed in the incidence of bleeding, postoperative pancreatitis, or perforation between the two groups. All patients with pancreatitis had mild cases with the exception of one patient who had moderate pancreatitis, as classified by Cotton’s criteria. All cases of pancreatitis resolved with medical treatment. Bleeding was successfully treated with balloon catheter compression or argon plasma coagulation (APC), and none of the patients required angiography or surgery.
Table 3
Complications
 
EST + EPLBD (n = 34)
EST (n = 36)
P value
Pancreatitis (%)
5.9
22.2
0.085
Hemorrhage (%)
2.9
5.6
0.999
Perforation (%)
0
0
0.999
Total (%)
8.8
25
0.112

Discussion

Since the study by Kawai et al. in 1974 [12], EST has been widely accepted as the standard endoscopic treatment for common bile duct stones. However, treatment of common bile duct stones with EST alone is often difficult in patients with large, multiple, or barrel-shaped stones or distal bile duct strictures [14, 13, 14].
Several studies have compared the usefulness of EST and EST + EPLBD [1318]. Some showed no significant difference in treatment results, whereas others reported that EST + EPLBD reduced the operative time, increased the rate of successful stone removal, and reduced the rate of ML use. In 2012, Feng et al. [19] performed a meta-analysis comparing EST and EPLBD. According to their findings, the successful stone removal rate in patients with common bile duct stones treated with EPLBD was 97.35 %, 87.87 % were successful in the first session, indicating favorable results. However, the differences between EPLBD and EST were not statistically significant. In addition, in patients with large stones, EML use did not differ significantly between the two groups, and the occurrence rate of bleeding, an early accidental event, was significantly lower in the EPLBD group. No consensus has been reached based on previous studies.
In our study, there was no difference in stone removal rates, which is consistent with the earlier reports [1318]. In contrast, our study showed that the complete stone removal rate in the first session was significantly higher in the EST + EPLBD group than in the EST group. In addition, EST + EPLBD use required significantly fewer sessions to achieve complete stone removal. Although these results were the same as those of Kim et al. [16], no differences were noted between EST + EPLBD and EST in the other studies [15, 18]. Kim et al. [16] attributed failure of complete stone removal in the first session to the presence of large and/or multiple stones. Differences in previous study results are likely attributable to the differences in the sizes and numbers of stones in the patients examined. Without the concurrent use of ML, it is often difficult to remove large stones using conventional EST alone. Moreover, a larger incision of papillary muscles is required, which increases the risk of serious complications such as bleeding and duodenal wall perforation [13, 14, 2022]. Therefore, large stones can usually be more safely and securely removed using conventional EST with ML for stone fragmentation [14, 23]. However, incomplete removal of stone fragments is a risk factor for recurrent stones [6, 7] and stone removal using ML often fails in patients with large stones [16, 24, 25]. In our study, the rate of ML use was significantly lower with EST + EPLBD than with EST. Although similar results have been reported by other investigators [8, 13, 16, 26], there was no difference in the rate of ML use between the EST and EST + EPLBD groups in a previous study [18]. In previous studies comparing EST and EST + EPLBD, the rates of ML use during EST ranged from 9 to 33 %, showing a marked difference from the 94 % rate of ML use in the present study. This may be because the mean diameter of the common bile duct stones was larger in our study than that in previous studies. Our results suggest that EST + EPLBD decreases the frequency of ML use for large or multiple stones, decreasing the number of remnant stone fragments that cannot be confirmed with endoscopic retrograde cholangiography. However, in patients with large stones and a tapered lower common bile duct, stone removal is often difficult with concurrent EST + EPLBD without ML use. Therefore, ML use is determined by bile duct form and stone diameter.
Operative time was also shorter with EST + EPLBD than with EST alone. This result is valid considering the rate of complete stone removal in the first session and the rate of ML use. Taken together, all of our results suggest that EST + EPLBD can achieve greater dilation of the bile duct opening than conventional EST alone, thus facilitating stone removal.
Complication rates did not differ significantly between the EST and EST + EPLBD groups. Kim et al. reported that the rate of accidental events in EST + EPLBD patients was 8.3 % (0–17.0 %) and the incidence of pancreatitis was 2.4 % (0–13.2 %), consisting mostly of mild-to-moderate pancreatitis [27]. Our results showed no occurrences of serious pancreatitis in the EST + EPLBD patients, and the incidence of all complications was 8.8 %, which is comparable to the rates reported in previous studies. No significant differences in the occurrence of pancreatitis were observed between the EST and EST + EPLBD groups. The similarity in pancreatitis rates in the EST + EPLBD and EST groups is attributable to the reduced effects of the separation of the pancreatic duct from the biliary orifice by EST before balloon dilation, indicating that additional EST before EPLBD may decrease the incidence of pancreatitis [13, 16, 18, 26]. Bleeding occurred in one patient in the EST + EPLBD group and in two patients in the EST group. Hemostasis was achievable in both groups by APC or compression with a retrieval balloon, and there were no significant differences between the two groups. However, Ersoz et al. [8] reported that the bleeding rate in patients receiving EST + EPLBD was 9 %, with the risk of bleeding being particularly high in those with a tapered distal bile duct. In such a case, balloon dilation should be performed only after careful consideration. We advocate morphological evaluation and diameter measurement of the distal bile duct because these data are important for performing EST + EPLBD. This recommendation is also intended to prevent perforation, which did not occur in our study.
Treatment using EST reduces the function of Oddi’s sphincter and may cause long-term problems such as recurrent bile duct stones and repeated retrograde cholangitis [28]. Since EST + EPLBD can theoretically achieve greater dilation of the bile duct opening than EST, the decrease in postoperative Oddi’s sphincter function is considered to be equivalent to or greater than that observed with EST. Therefore, further study of long-term outcomes is required.

Conclusion

The results of the present study show that EST + EPLBD allowed complete stone removal in fewer sessions and in a shorter time frame as compared to EST, without increasing the number of accidental events in the treatment of large (≥15 mm) or multiple (≥ three) stones. The final successful treatment rates did not differ between the EST + EPLBD and EST groups, suggesting that the indications for EST + EPLBD should be determined with care. Future studies with larger sample sizes for more detailed examination, including assessment of long-term outcomes, are necessary.

Acknowledgements

We are grateful to all the clinicians involved in the management and treatment of the patients.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​4.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

KT was involved in the study design and manuscript drafting. KT, MI, MT, and NY performed the endoscopic treatment. KT, MI, MT, TS, and CT performed data collection and statistical analyses. NY, TS, and HH provided advice on the manuscript. NY and HH participated in the study design and helped in manuscript drafting. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Binmoeller KF, Schafer TW. Endoscopic management of bile duct stones. J Clin Gastroenterol. 2001;32(2):106–18.CrossRefPubMed Binmoeller KF, Schafer TW. Endoscopic management of bile duct stones. J Clin Gastroenterol. 2001;32(2):106–18.CrossRefPubMed
2.
Zurück zum Zitat Cipolletta L, Costamagna G, Bianco MA, Rotondano G, Piscopo R, Mutignani M, et al. Endoscopic mechanical lithotripsy of difficult common bile duct stones. Br J Surg. 1997;84(10):1407–9.CrossRefPubMed Cipolletta L, Costamagna G, Bianco MA, Rotondano G, Piscopo R, Mutignani M, et al. Endoscopic mechanical lithotripsy of difficult common bile duct stones. Br J Surg. 1997;84(10):1407–9.CrossRefPubMed
3.
Zurück zum Zitat Neuhaus H. Endoscopic and percutaneous treatment of difficult bile duct stones. Endoscopy. 2003;35(8):S31–4.CrossRefPubMed Neuhaus H. Endoscopic and percutaneous treatment of difficult bile duct stones. Endoscopy. 2003;35(8):S31–4.CrossRefPubMed
4.
Zurück zum Zitat Seitz U, Bapaye A, Bohnacker S, Navarrete C, Maydeo A, Soehendra N. Advances in therapeutic endoscopic treatment of common bile duct stones. World J Surg. 1998;22(11):1133–44.CrossRefPubMed Seitz U, Bapaye A, Bohnacker S, Navarrete C, Maydeo A, Soehendra N. Advances in therapeutic endoscopic treatment of common bile duct stones. World J Surg. 1998;22(11):1133–44.CrossRefPubMed
5.
6.
Zurück zum Zitat Ando T, Tsuyuguchi T, Okugawa T, Saito M, Ishihara T, Yamaguchi T, et al. Risk factors for recurrent bile duct stones after endoscopic papillotomy. Gut. 2003;52(1):116–21.CrossRefPubMedPubMedCentral Ando T, Tsuyuguchi T, Okugawa T, Saito M, Ishihara T, Yamaguchi T, et al. Risk factors for recurrent bile duct stones after endoscopic papillotomy. Gut. 2003;52(1):116–21.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Saito M, Tsuyuguchi T, Yamaguchi T, Ishihara T, Saisho H. Long-term outcome of endoscopic papillotomy for choledocholithiasis with cholecystolithiasis. Gastrointest Endosc. 2000;51(5):540–5.CrossRefPubMed Saito M, Tsuyuguchi T, Yamaguchi T, Ishihara T, Saisho H. Long-term outcome of endoscopic papillotomy for choledocholithiasis with cholecystolithiasis. Gastrointest Endosc. 2000;51(5):540–5.CrossRefPubMed
8.
Zurück zum Zitat Ersoz G, Tekesin O, Ozutemiz AO, Gunsar F. Biliary sphincterotomy plus dilation with a large balloon for bile duct stones that are difficult to extract. Gastrointest Endosc. 2003;57(2):156–9.CrossRefPubMed Ersoz G, Tekesin O, Ozutemiz AO, Gunsar F. Biliary sphincterotomy plus dilation with a large balloon for bile duct stones that are difficult to extract. Gastrointest Endosc. 2003;57(2):156–9.CrossRefPubMed
9.
Zurück zum Zitat Tsujino T, Komatsu Y, Isayama H, Hirano K, Sasahira N, Yamamoto N, et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol. 2005;3(4):376–83.CrossRefPubMed Tsujino T, Komatsu Y, Isayama H, Hirano K, Sasahira N, Yamamoto N, et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol. 2005;3(4):376–83.CrossRefPubMed
10.
Zurück zum Zitat Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc. 2004;59(7):845–64.CrossRefPubMed Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc. 2004;59(7):845–64.CrossRefPubMed
11.
Zurück zum Zitat Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37(3):383–93.CrossRefPubMed Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37(3):383–93.CrossRefPubMed
12.
Zurück zum Zitat Kawai K, Akasaka Y, Murakami K, Tada M, Koli Y. Endoscopic sphincterotomy of the ampulla of Vater. Gastrointest Endosc. 1974;20(4):148–51.CrossRefPubMed Kawai K, Akasaka Y, Murakami K, Tada M, Koli Y. Endoscopic sphincterotomy of the ampulla of Vater. Gastrointest Endosc. 1974;20(4):148–51.CrossRefPubMed
13.
Zurück zum Zitat Itoi T, Itokawa F, Sofuni A, Kurihara T, Tsuchiya T, Ishii K, et al. Endoscopic sphincterotomy combined with large balloon dilation can reduce the procedure time and fluoroscopy time for removal of large bile duct stones. Am J Gastroenterol. 2009;104(3):560–5.CrossRefPubMed Itoi T, Itokawa F, Sofuni A, Kurihara T, Tsuchiya T, Ishii K, et al. Endoscopic sphincterotomy combined with large balloon dilation can reduce the procedure time and fluoroscopy time for removal of large bile duct stones. Am J Gastroenterol. 2009;104(3):560–5.CrossRefPubMed
14.
Zurück zum Zitat Stefanidis G, Viazis N, Pleskow D, Manolakopoulos S, Theocharis L, Christodoulou C, et al. Large balloon dilation vs mechanical lithotripsy for the management of large bile duct stones: a prospective randomized study. Am J Gastroenterol. 2011;106(2):278–85.CrossRefPubMed Stefanidis G, Viazis N, Pleskow D, Manolakopoulos S, Theocharis L, Christodoulou C, et al. Large balloon dilation vs mechanical lithotripsy for the management of large bile duct stones: a prospective randomized study. Am J Gastroenterol. 2011;106(2):278–85.CrossRefPubMed
15.
Zurück zum Zitat Kim HG, Cheon YK, Cho YD, Moon JH, Park Do H, Lee TH, et al. Small sphincterotomy combined with endoscopic papillary large balloon dilation versus sphincterotomy. World J Gastroenterol. 2009;15(34):4298–304.CrossRefPubMedPubMedCentral Kim HG, Cheon YK, Cho YD, Moon JH, Park Do H, Lee TH, et al. Small sphincterotomy combined with endoscopic papillary large balloon dilation versus sphincterotomy. World J Gastroenterol. 2009;15(34):4298–304.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Kim TH, Oh HJ, Lee JY, Sohn YW. Can a small endoscopic sphincterotomy plus a large-balloon dilation reduce the use of mechanical lithotripsy in patients with large bile duct stones? Surg Endosc. 2011;25(10):3330–7.CrossRefPubMed Kim TH, Oh HJ, Lee JY, Sohn YW. Can a small endoscopic sphincterotomy plus a large-balloon dilation reduce the use of mechanical lithotripsy in patients with large bile duct stones? Surg Endosc. 2011;25(10):3330–7.CrossRefPubMed
17.
Zurück zum Zitat García-Cano J, Arana LT, Ayllón CJ, Chicano MV, Fernández RM, Sánchez LS, et al. Biliary sphincterotomy dilation for the extraction of difficult common bile duct stones. Rev Esp Enferm Dig. 2009;101(8):541–5.PubMed García-Cano J, Arana LT, Ayllón CJ, Chicano MV, Fernández RM, Sánchez LS, et al. Biliary sphincterotomy dilation for the extraction of difficult common bile duct stones. Rev Esp Enferm Dig. 2009;101(8):541–5.PubMed
18.
Zurück zum Zitat Heo JH, Kang DH, Jung HJ, Kwon DS, An JK, Kim BS, et al. Endoscopic sphincterotomy plus large-balloon dilation versus endoscopic sphincterotomy for removal of bile-duct stones. Gastrointest Endosc. 2007;66(4):720–6.CrossRefPubMed Heo JH, Kang DH, Jung HJ, Kwon DS, An JK, Kim BS, et al. Endoscopic sphincterotomy plus large-balloon dilation versus endoscopic sphincterotomy for removal of bile-duct stones. Gastrointest Endosc. 2007;66(4):720–6.CrossRefPubMed
19.
Zurück zum Zitat Feng Y, Zhu H, Chen X, Xu S, Cheng W, Ni J, et al. Comparison of endoscopic papillary large balloon dilation and endoscopic sphincterotomy for retrieval of choledocholithiasis: a meta-analysis of randomized controlled trials. J Gastroenterol. 2012;47(6):655–63.CrossRefPubMed Feng Y, Zhu H, Chen X, Xu S, Cheng W, Ni J, et al. Comparison of endoscopic papillary large balloon dilation and endoscopic sphincterotomy for retrieval of choledocholithiasis: a meta-analysis of randomized controlled trials. J Gastroenterol. 2012;47(6):655–63.CrossRefPubMed
20.
Zurück zum Zitat Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335(13):909–18.CrossRefPubMed Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335(13):909–18.CrossRefPubMed
21.
Zurück zum Zitat Mallery JS, Baron TH, Dominitz JA, Goldstein JL, Hirota WK, Jacobson BC, et al. Complications of ERCP. Gastrointest Endosc. 2003;57(6):633–8.CrossRefPubMed Mallery JS, Baron TH, Dominitz JA, Goldstein JL, Hirota WK, Jacobson BC, et al. Complications of ERCP. Gastrointest Endosc. 2003;57(6):633–8.CrossRefPubMed
22.
Zurück zum Zitat Bergman JJ, van der Mey S, Rauws EA, Tijssen JG, Gouma DJ, Tytgat GN, et al. Long-term follow-up after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age. Gastrointest Endosc. 1996;44(6):643–9.CrossRefPubMed Bergman JJ, van der Mey S, Rauws EA, Tijssen JG, Gouma DJ, Tytgat GN, et al. Long-term follow-up after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age. Gastrointest Endosc. 1996;44(6):643–9.CrossRefPubMed
23.
Zurück zum Zitat Leung JW, Tu R. Mechanical lithotripsy for large bile duct stones. Gastrointest Endosc. 2004;59(6):688–90.CrossRefPubMed Leung JW, Tu R. Mechanical lithotripsy for large bile duct stones. Gastrointest Endosc. 2004;59(6):688–90.CrossRefPubMed
24.
Zurück zum Zitat Lee SH, Park JK, Yoon WJ, Lee JK, Ryu JK, Kim YT, et al. How to predict the outcome of endoscopic mechanical lithotripsy in patients with difficult bile duct stones? Scand J Gastroenterol. 2007;42(8):1006–10.CrossRefPubMed Lee SH, Park JK, Yoon WJ, Lee JK, Ryu JK, Kim YT, et al. How to predict the outcome of endoscopic mechanical lithotripsy in patients with difficult bile duct stones? Scand J Gastroenterol. 2007;42(8):1006–10.CrossRefPubMed
25.
Zurück zum Zitat Chang WH, Chu CH, Wang TE, Chen MJ, Lin CC. Outcome of simple use of mechanical lithotripsy of difficult common bile duct stones. World J Gastroenterol. 2005;11(4):593–6.CrossRefPubMedPubMedCentral Chang WH, Chu CH, Wang TE, Chen MJ, Lin CC. Outcome of simple use of mechanical lithotripsy of difficult common bile duct stones. World J Gastroenterol. 2005;11(4):593–6.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Minami A, Hirose S, Nomoto T, Hayakawa S. Small sphincterotomy combined with papillary dilation with large balloon permits retrieval of large stones without mechanical lithotripsy. World J Gastroenterol. 2007;13(15):2179–82.CrossRefPubMedPubMedCentral Minami A, Hirose S, Nomoto T, Hayakawa S. Small sphincterotomy combined with papillary dilation with large balloon permits retrieval of large stones without mechanical lithotripsy. World J Gastroenterol. 2007;13(15):2179–82.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Kim JH, Yang MJ, Hwang JC, Yoo BM. Endoscopic papillary large balloon dilation for the removal of bile duct stones. World J Gastroenterol. 2013;19(46):8580–94.CrossRefPubMedPubMedCentral Kim JH, Yang MJ, Hwang JC, Yoo BM. Endoscopic papillary large balloon dilation for the removal of bile duct stones. World J Gastroenterol. 2013;19(46):8580–94.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Yasuda I, Fujita N, Maguchi H, Hasebe O, Igarashi Y, Murakami A, et al. Long-term outcomes after endoscopic sphincterotomy versus endoscopic papillary balloon dilation for bile duct stones. Gastrointest Endosc. 2010;72(6):1185–91.CrossRefPubMed Yasuda I, Fujita N, Maguchi H, Hasebe O, Igarashi Y, Murakami A, et al. Long-term outcomes after endoscopic sphincterotomy versus endoscopic papillary balloon dilation for bile duct stones. Gastrointest Endosc. 2010;72(6):1185–91.CrossRefPubMed
Metadaten
Titel
Comparison of the usefulness of endoscopic papillary large-balloon dilation with endoscopic sphincterotomy for large and multiple common bile duct stones
verfasst von
Kouhei Tsuchida
Mari Iwasaki
Misako Tsubouchi
Tsunehiro Suzuki
Chieko Tsuchida
Naoto Yoshitake
Takako Sasai
Hideyuki Hiraishi
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
BMC Gastroenterology / Ausgabe 1/2015
Elektronische ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-015-0290-6

Weitere Artikel der Ausgabe 1/2015

BMC Gastroenterology 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.